Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › (-)-mefloquine to block puringergic receptors and to treat movement or neurodegenerative disorders

(-)-mefloquine to block puringergic receptors and to treat movement or neurodegenerative disorders

US Patent 6197788 · Granted Mar 6, 2001

Estimated economic value: $141,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antihistamines in combination with a range of substances for improved health2022
Antihistamines combined with dietary supplements for improved health2017
Imidazole derivatives2013
Diazole derivatives2012
Imidazole derivatives2011
Imidazole derivatives2011
Pyrazine-2-carboxyamide derivatives2011
Thiazole-4-carboxyamide derivatives2010
Thiazolo[4,5-C]pyridine derivatives2010
Triazol[4,5-d] pyramidine derivatives and their use as purinergic receptor antag2009
Imidazole derivatives2009
Naphthyridin derivatives2009